Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Group A (Qurs-e-Zayabitus Khas and Qurs-e-Tabasheer): Qurs-e-Zayabitus Khas and Qurs-e-Tabasheer will be prepared in a single batch, according to the standard method described in Nation
Sponsors
Central Research Institute of Unani Medicine Hyderabad
Eligibility
Inclusion criteria
Inclusion criteria: Patients of any sex aged 30-65 years Fasting plasma glucose levels between 126 and 175 mg/dL or Post Prandial plasma glucose levels between 200 and 250 mg/dL (2 hours after ingestion of 75 gm of glucose in 300 ml of water) or HbA1c level between 6.5 and 8% and Presence of any of the following symptoms and signs of diabetes mellitus (2 hours after ingestion of 75 gm of glucose in 300 ml of water) or HbA1c level between 6.5 and 8% and Presence of any symptoms and signs of diabetes mellitus
Exclusion criteria
Exclusion criteria: Subjects with FPG level >175 mg/dL and/ or PP plasma glucose level >250 mg/dL and/ or HbA1c >8% Subjects on Insulin therapy Type 2 DM with complications/ Secondary DM/Type 1 DM Significant pulmonary/ cardiovascular/ hepato-renal dysfunction Known cases of immunocompromised states (HIV/ AIDS, etc.)/ Malignancies Obese subjects (BMI >30) Pregnant and lactating women Drug addicts/Alcoholics Patient not willing to attend treatment schedule regularly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Reduction in Fasting and PP plasma glucose (2-hPG) level 2.Decrease in HbA1c level by more than equal to 1 percent as compared to baseline 3.Improvement in the following symptoms of DhayÄ?bÄ«á¹us HÌ£Ä?rr Qism ThÄ?nÄ« (Type 2 Diabetes Mellitus) on 0-100mm Timepoint: At baseline, 2wk, 4wk, 6wk, 8wk, 10wk, and 12wk | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemogram, LFT, RFT, FPG, Urine R/M examinationTimepoint: At baseline and 8th followup | — |
Countries
India
Contacts
Public ContactTasleem Ahmed
Central Research Institute Of Unani Medicine,
Outcome results
None listed